Approval · Notice of Compliance 30028 · 2023
COMIRNATY: Notice of Compliance 30028
Issued February 1, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30028
- Date
- February 1, 2023
- Company
- Biontech Manufacturing GmbhMainz, Rheinland-Pfalz, Germany
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMIRNATY | Not yet assigned | — |
Medicinal ingredients
- TOZINAMERAN 30 MCG per DOSE